RAD21 and prostate carcinoma: We confirmed that in MCF7 cells RAD21 binds a putative enhancer for MYC that we termed C SNP, due to its proximity to a SNP associated with colorectal (CRC) and prostate cancer [27], [29], [80], [83]–[89].